BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical ...

After the loss of his mother to ALS, a Kansas City man gave two Chiefs fans who are ALS patients the tour of a lifetime.

New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...

FRIDAY, Aug. 15, 2025 (HealthDay News) — For the first time, scientists have created a brain implant that can “hear” and ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 15, 2025 (HealthDay News) — Breathing problems are common among people with ...

The 67-year-old actress has landed a mysterious role in the upcoming third season of the HBO drama and she is delighted to be starring alongside her old friend - who announced in April that he is ...

Sharon Stone isn’t afraid to play the villain, and she revealed that she has a “bit of a moral code” when it comes to portraying evil characters in projects.

Case Western Reserve University scientists have discovered a subset of spinal cord interneurons that boost breathing under ...

Pharmaust Limited ( ($AU:NUZ) ) has issued an announcement. Neurizon Therapeutics Limited announced a delay in the FDA’s review timeline for its ...

Brainstorm Cell Therapeutics ( ($BCLI) ) has released its Q2 earnings. Here is a breakdown of the information Brainstorm Cell Therapeutics ...

SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.